This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration. Need a new registration confirmation email? Click here
BEIJING, Dec. 13, 2012 (GLOBE NEWSWIRE) --
Dehaier Medical Systems Ltd. (Nasdaq:DHRM) ("Dehaier"), an emerging leader in the development, assembly, marketing and sale of medical devices and homecare medical products in China, today announced that it has obtained Megapixels software copyrights for its DHR C-Arm X Ray Machine.
The application enhances the Dehaier's DHR C-Arm X Ray Machine, by offering improved image quality and easier image acquisition to strengthen the customer experience. The software can also help to improve patient management, increase ease of use and image processing for users. The upgraded C-Arm X Ray Machine can produce optimized images with minimal user involvement through its advanced imaging technology.
Mr. Ping Chen, CEO of Dehaier, commented, "Customers benefit from our continued innovation and focus on creating unparalleled products. Anticipating and addressing market need and devoting research and development to strengthen our product pipeline are critical missions to expand our brand awareness and grow market share."
About Dehaier Medical Systems Ltd.
Dehaier is an emerging leader in the development, assembly, marketing and sale of medical products, including respiratory and oxygen homecare medical products. The company develops and assembles its own branded medical devices and homecare medical products from third-party components. The company also distributes products designed and manufactured by other companies, including medical devices from IMD (Italy), Welch Allyn (USA), HEYER (Germany), Timesco (UK), eVent Medical (US) and JMS (Japan). Dehaier's technology is based on six patents, ten software copyrights and proprietary technology. More information may be found at
This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events, government approvals or performance, and underlying assumptions and other statements that are other than statements of historical facts, including in particular any implications regarding the future validity of its copyrights. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, future developments in payment for and demand for medical equipment and services, implementation of and performance under the joint venture agreement by all parties, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.
CONTACT: Dehaier Medical Systems Limited
Dehaier Medical Systems Limited